Bishoy M. Faltas: We are looking for Postdocs Interested in studying Cancer Evolution
Bishoy M. Faltas, Chief Research Officer at the Englander Institute for Precision Medicine and an Associate Professor of Medicine and Cell and Developmental Biology at Weill Cornell Medicine, shared a post on X:
“Please retweet!
We are looking for outstanding postdocs interested in studying cancer evolution!
See our recent work.
Research Areas:
- APOBEC3 induced mutations & RNA editing in cancer evolution.
- Extrachromosomal DNA & therapy resistance.
- Role of the noncoding genome in cancer evolution.
- Bio-Digital Avatars for personalized therapy.
- Translational cancer drug development.
Click here for more details.
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Authors: Duy D. Nguyen, et al.
Dr. Bishoy Morris Faltas is the Chief Research Officer at the Englander Institute for Precision Medicine and an Associate Professor of Medicine and Cell and Developmental Biology at Weill Cornell Medicine. He also serves as the Director of Bladder Cancer Research at the Englander Institute for Precision Medicine and is an Associate Attending at NewYork-Presbyterian Hospital. A member of the Editorial Board of The ASCO Post, Dr. Faltas is focused on studying bladder cancer, a disease for which there are currently no uniformly curative therapies.
For more Updates, Follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023